Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12405326 | 0.87 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1CALK | |
| SCHEMBL29977301 | 0.82 | GRM5 (0.45) | CACNA2D1CACNB2CACNA1CALDH1A1CYP1A2 | |
| SCHEMBL20044985 | 0.80 | CACNA2D1 (0.37) | CACNA2D1CACNB2CACNA1CALK | |
| SCHEMBL20044978 | 0.79 | HSD17B10 (0.38) | CACNA2D1CACNB2CACNA1CALDH1A1CYP1A2 | |
| SCHEMBL10022715 | 0.79 | CACNA2D1 (0.39) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL715009 | 0.79 | CACNA2D1 (0.39) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL4462408 | 0.75 | CACNA2D1 (0.41) | CACNA2D1CACNB2CACNA1CALDH1A1HPGD | |
| SCHEMBL29537640 | 0.75 | CACNA2D1 (0.41) | CACNA2D1CACNB2CACNA1CALDH1A1HPGD | |
| SCHEMBL10034266 | 0.75 | CACNA2D1 (0.33) | CACNA2D1CACNB2CACNA1CCYP1A2 | |
| SCHEMBL22208088 | 0.75 | ALK (0.31) | CACNA2D1CACNB2CACNA1CALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080265750-A1 | Triphenylene Compounds, Method of Manufacturing the Same and Organic Electroluminescent Devices Employing the Same | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080265750-A1 | Triphenylene Compounds, Method of Manufacturing the Same and Organic Electroluminescent Devices Employing the Same | SMARCC2, SMARCC1, TERT | CACNA2D1 1023/4885CACNB2 1466/4885CACNA1C 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.